Is it safe?
Can TMO take a bad year?
Thermo Fisher Scientific carries $38.5B of net debt at 4.14× EBITDA: a heavy load to carry through a bad year.
$38.5B
Net debt · as at Q2 2026 · over four years of earnings before interest, tax and depreciation, heavy
- Net debt / EBITDA
- 4.14×
Net debt / EBITDA · 3.38× a year ago · the load is going up
- Altman Z-score
- 3.46
Altman Z-score · safe zone, above 3
- Interest cover
- 5.55×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ2 2026
- $42.5B
- Cash and short-term investments
- $4.06B
- Net debt
- $38.5B
- EBITDA, trailing twelve months
- $9.30B
- Operating profit, trailing twelve months
- $8.15B
- Debt / equity
- 0.81×
- Total debt / EBITDA
- 4.57×
- Annualised volatilitytwo years of daily moves
- 31%
- Worst drawdown on file
- −41%
- Below its 52-week high
- −0.66%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Diagnostics & Research
Ranks #9 of 29 by Smart Score